User login
Two researchers have joined Stand Up To Cancer’s scientific advisory committee, which directs the organization’s research initiatives, reviews grant proposals, and oversees active grants.
One new committee member is John D. Carpten, PhD, of the University of Southern California in Los Angeles. Dr. Carpten’s research encompasses several cancer types and focuses on the use of genomic technologies and bioinformatics analysis.
The other new committee member is Roderic I. Pettigrew, MD, PhD, of Texas A&M University in College Station. Dr. Pettigrew is known for pioneering four-dimensional imaging of the cardiovascular system using MRI.
In other news, Fox Chase Cancer Center in Philadelphia has appointed five new endowed chairs. The chair holders “will have new resources to strengthen [the center’s] efforts in various areas of cancer research and to implement more effective cancer treatments,” according to Fox Chase.
Hossein Borghaei, DO, now holds the Gloria and Edmund M. Dunn Chair in Thoracic Oncology. Dr. Borghaei conducts research focused on the development of new cancer treatments, particularly immunotherapies and monoclonal antibodies.
Margie L. Clapper, PhD, holds the Samuel M.V. Hamilton Chair in Cancer Prevention. Dr. Clapper is known for creating one of the first programs in the United States to focus on reducing the risk of cancer in high-risk patients and supporting the early detection and prevention of cancers.
Erica Golemis, PhD, holds the William Wikoff Smith Chair in Cancer Research. Dr. Golemis studies changes in cell signaling associated with tumor development and progression, as well as cancer treatment resistance.
Mariusz A. Wasik, MD, holds the Donald E. and Shirley C. Morel, Stanley and Stella Bayster Chair in Molecular Diagnostics. Dr. Wasik’s research is focused on aberrant cell signaling and oncogenic mutations in lymphomas, as well as cell transformation driven by ALK.
Johnathan R. Whetstine, PhD, holds the Jack Schultz Chair in Basic Science. Dr. Whetstine studies epigenetic mechanisms that regulate cell cycle progression, impact cancer therapy, and drive copy gain, amplifications, and drug resistance.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.
Two researchers have joined Stand Up To Cancer’s scientific advisory committee, which directs the organization’s research initiatives, reviews grant proposals, and oversees active grants.
One new committee member is John D. Carpten, PhD, of the University of Southern California in Los Angeles. Dr. Carpten’s research encompasses several cancer types and focuses on the use of genomic technologies and bioinformatics analysis.
The other new committee member is Roderic I. Pettigrew, MD, PhD, of Texas A&M University in College Station. Dr. Pettigrew is known for pioneering four-dimensional imaging of the cardiovascular system using MRI.
In other news, Fox Chase Cancer Center in Philadelphia has appointed five new endowed chairs. The chair holders “will have new resources to strengthen [the center’s] efforts in various areas of cancer research and to implement more effective cancer treatments,” according to Fox Chase.
Hossein Borghaei, DO, now holds the Gloria and Edmund M. Dunn Chair in Thoracic Oncology. Dr. Borghaei conducts research focused on the development of new cancer treatments, particularly immunotherapies and monoclonal antibodies.
Margie L. Clapper, PhD, holds the Samuel M.V. Hamilton Chair in Cancer Prevention. Dr. Clapper is known for creating one of the first programs in the United States to focus on reducing the risk of cancer in high-risk patients and supporting the early detection and prevention of cancers.
Erica Golemis, PhD, holds the William Wikoff Smith Chair in Cancer Research. Dr. Golemis studies changes in cell signaling associated with tumor development and progression, as well as cancer treatment resistance.
Mariusz A. Wasik, MD, holds the Donald E. and Shirley C. Morel, Stanley and Stella Bayster Chair in Molecular Diagnostics. Dr. Wasik’s research is focused on aberrant cell signaling and oncogenic mutations in lymphomas, as well as cell transformation driven by ALK.
Johnathan R. Whetstine, PhD, holds the Jack Schultz Chair in Basic Science. Dr. Whetstine studies epigenetic mechanisms that regulate cell cycle progression, impact cancer therapy, and drive copy gain, amplifications, and drug resistance.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.
Two researchers have joined Stand Up To Cancer’s scientific advisory committee, which directs the organization’s research initiatives, reviews grant proposals, and oversees active grants.
One new committee member is John D. Carpten, PhD, of the University of Southern California in Los Angeles. Dr. Carpten’s research encompasses several cancer types and focuses on the use of genomic technologies and bioinformatics analysis.
The other new committee member is Roderic I. Pettigrew, MD, PhD, of Texas A&M University in College Station. Dr. Pettigrew is known for pioneering four-dimensional imaging of the cardiovascular system using MRI.
In other news, Fox Chase Cancer Center in Philadelphia has appointed five new endowed chairs. The chair holders “will have new resources to strengthen [the center’s] efforts in various areas of cancer research and to implement more effective cancer treatments,” according to Fox Chase.
Hossein Borghaei, DO, now holds the Gloria and Edmund M. Dunn Chair in Thoracic Oncology. Dr. Borghaei conducts research focused on the development of new cancer treatments, particularly immunotherapies and monoclonal antibodies.
Margie L. Clapper, PhD, holds the Samuel M.V. Hamilton Chair in Cancer Prevention. Dr. Clapper is known for creating one of the first programs in the United States to focus on reducing the risk of cancer in high-risk patients and supporting the early detection and prevention of cancers.
Erica Golemis, PhD, holds the William Wikoff Smith Chair in Cancer Research. Dr. Golemis studies changes in cell signaling associated with tumor development and progression, as well as cancer treatment resistance.
Mariusz A. Wasik, MD, holds the Donald E. and Shirley C. Morel, Stanley and Stella Bayster Chair in Molecular Diagnostics. Dr. Wasik’s research is focused on aberrant cell signaling and oncogenic mutations in lymphomas, as well as cell transformation driven by ALK.
Johnathan R. Whetstine, PhD, holds the Jack Schultz Chair in Basic Science. Dr. Whetstine studies epigenetic mechanisms that regulate cell cycle progression, impact cancer therapy, and drive copy gain, amplifications, and drug resistance.
Movers in Medicine highlights career moves and personal achievements by hematologists and oncologists. Did you switch jobs, take on a new role, climb a mountain? Tell us all about it at hematologynews@mdedge.com, and you could be featured in Movers in Medicine.